P3 Health Partners Inc. 8K

P3 Health Partners Inc. provided a pro forma balance sheet reflecting a large debt-to-equity conversion and a $30 million Series D preferred stock issuance that deleverage and recapitalize the company.

P3 Health Partners Inc. filed pro forma condensed consolidated balance sheet information as of March 31, 2026 to reflect the impact of a significant debt conversion and the issuance of a new Series D preferred stock financing. The pro forma adjustments show a $195.7 million reduction in long-term debt through conversion into preferred equity (Series A, B, and C), which eliminates a stockholders’ deficit and materially deleverages the balance sheet. In addition, the company records $30.0 million of cash proceeds from the issuance of Series D preferred stock, increasing total assets and stockholders’ equity by the same amount. Collectively, these transactions reduce total liabilities to approximately $611.7 million, increase total stockholders’ equity to about $82.1 million from a prior deficit, and result in total pro forma assets of $704.2 million, indicating a strengthened capital structure and improved balance sheet position.

Filing Facts

CIK

1832511

Ticker

-

Form

8K

Source Type

sec

Accession

0001832511-26-000024

Alert Tier

7